What medications interact with Koffex-DM (dextromethorphan)

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Koffex-DM (Dextromethorphan) Medication Interactions

Koffex-DM (dextromethorphan) has several significant drug interactions, with monoamine oxidase inhibitors (MAOIs) being the most dangerous contraindicated combination due to risk of potentially fatal serotonin syndrome.

Major Contraindicated Interactions

  • MAOIs (Monoamine Oxidase Inhibitors): Absolutely contraindicated with dextromethorphan due to risk of potentially life-threatening serotonin syndrome. This includes phenelzine, tranylcypromine, isocarboxazid, selegiline, and linezolid 1, 2

  • SSRIs (Selective Serotonin Reuptake Inhibitors): Combining dextromethorphan with SSRIs like sertraline, fluoxetine, or paroxetine significantly increases the risk of serotonin syndrome, characterized by mental status changes, neuromuscular hyperactivity, and autonomic instability 3, 4

  • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors): Similar to SSRIs, these medications can increase serotonin levels and lead to serotonin syndrome when combined with dextromethorphan 1

Moderate Interactions Requiring Caution

  • Tricyclic Antidepressants (TCAs): Concomitant use with dextromethorphan may increase serotonergic effects and risk of serotonin syndrome 1

  • Opioids: Combining dextromethorphan with opioids increases CNS depression and risk of serotonin syndrome, particularly with tramadol, meperidine, methadone, and fentanyl 1, 3

  • Quinidine: While sometimes intentionally combined therapeutically (as in Nuedexta), quinidine inhibits CYP2D6 metabolism of dextromethorphan, significantly increasing dextromethorphan plasma concentrations 5, 6

  • Stimulants: Amphetamine-class medications and possibly methylphenidate may increase risk of serotonin syndrome when combined with dextromethorphan 3

Other Notable Interactions

  • Over-the-counter medications: Products containing chlorpheniramine or other antihistamines may have additive CNS depressant effects 3

  • Herbal supplements: St. John's Wort and L-tryptophan supplements can increase serotonin levels and should be avoided with dextromethorphan 3

  • Illicit drugs: MDMA (ecstasy), methamphetamine, cocaine, and LSD can significantly increase the risk of serotonin syndrome when combined with dextromethorphan 3, 2

Signs of Serotonin Syndrome to Monitor

  • Early symptoms develop rapidly (within 24-48 hours) and include agitation, confusion, tremor, hyperreflexia, and clonus 4

  • Advanced symptoms include hyperthermia, tachycardia, fever, seizures, arrhythmias, and potentially death 4, 3

Risk Mitigation Strategies

  • Always check for potential drug interactions before prescribing or recommending dextromethorphan-containing products 2

  • Educate patients about avoiding over-the-counter medications without consulting a healthcare provider 1

  • When switching from MAOIs to other medications (or vice versa), ensure adequate washout periods (typically 2 weeks, 5 weeks for fluoxetine) 1

  • Be particularly cautious with elderly patients or those with multiple medications, as they may be at higher risk for adverse interactions 3

Common Pitfalls to Avoid

  • Failing to recognize that many over-the-counter cold and cough medications contain dextromethorphan 2, 7

  • Not considering the recreational abuse potential of dextromethorphan ("robotripping"), which can lead to intoxication delirium at high doses 8

  • Overlooking the fact that patients may not report all supplements or over-the-counter medications they are taking 3

References

Guideline

Monoamine Oxidase Inhibitors (MAOIs) in the Treatment of Depression and Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Risk of Serotonin Syndrome with Sertraline and Trazodone Combination

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Options for Anxiety and Depression in Patients with History of Serotonin Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dextromethorphan/quinidine sulfate for pseudobulbar affect.

Drugs of today (Barcelona, Spain : 1998), 2008

Research

Recreational use of dextromethorphan, "Robotripping"-A brief review.

The American journal on addictions, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.